The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Distinct neural mechanisms for the prosocial and rewarding properties of MDMA
Open accessPublished version of a preprint
Abstract
MDMA, which has both therapeutic and abuse potential, engages a brain region–specific serotonergic pathway to produce its prosocial effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mice, systemic administration of a prosocial dose of MDMA enhanced sociability in the three-chamber assay, an effect that was mimicked by direct infusion of MDMA into the NAc, prevented by pharmacological inhibition of the 5-HT transporter (SERT) or its genetic deletion, and blocked by direct infusion into the NAc of a 5-HT1b receptor antagonist [51].”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“In mice, systemic administration of a prosocial dose of MDMA enhanced sociability in the three-chamber assay, an effect that was mimicked by direct infusion of MDMA into the NAc, prevented by pharmacological inhibition of the 5-HT transporter (SERT) or its genetic deletion, and blocked by direct infusion into the NAc of a 5-HT1b receptor antagonist [51].”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“In mice, systemic administration of a prosocial dose of MDMA enhanced sociability in the three-chamber assay, an effect that was mimicked by direct infusion of MDMA into the NAc, prevented by pharmacological inhibition of the 5-HT transporter (SERT) or its genetic deletion, and blocked by direct infusion into the NAc of a 5-HT1b receptor antagonist [51].”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“In mice, systemic administration of a prosocial dose of MDMA enhanced sociability in the three-chamber assay, an effect that was mimicked by direct infusion of MDMA into the NAc, prevented by pharmacological inhibition of the 5-HT transporter (SERT) or its genetic deletion, and blocked by direct infusion into the NAc of a 5-HT1b receptor antagonist [51].”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“Furthermore, administration of methamphetamine, a potent DA releaser, did not enhance sociability [51].”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“This simple form of 5-HT1b receptor-triggered synaptic plasticity was subsequently found to be generated by bath application of OXT or MDMA [41,51], results consistent with the 5-HT releasing properties of these agents.”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“In contrast, the actions of MDMA on the DA transporter (DAT) were not required for this prosocial effect, as prior administration of a DAT inhibitor did not influence MDMA's effects in the three-chamber assay.”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“Because of its abuse potential and potential toxicity [51,177], it is unlikely that MDMA itself can ever be used as a daily treatment for sociability deficits.”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Moy, S. S., Nadler, J. J., Perez, A., Barbaro, R. P., Johns, J. M., Magnuson, T. R., Piven, J., & Crawley, J. N. (2004) · Genes, Brain and Behavior · doi:10.1111/j.1601-1848.2004.00076.x · Cited by 1,522 · cited 1×
“Social approach testing was performed similar to previously described methods (17).”
MethodThe Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin
Dölen, G., Darvishzadeh, A., Huang, K. W., & Malenka, R. C. (2013) · Nature · doi:10.1038/nature12518 · Cited by 1,161
Self-citationDrug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling
Lüscher, C., & Malenka, R. C. (2011) · Neuron · doi:10.1016/j.neuron.2011.01.017 · Cited by 1,105
Self-citationCircuit architecture of VTA dopamine neurons revealed by systematic input-output mapping
Beier, K. T., Steinberg, E. E., DeLoach, K. E., Xie, S., Miyamichi, K., Schwarz, L., Gao, X. J., Kremer, E. J., Malenka, R. C., & Luo, L. (2015) · Cell · doi:10.1016/j.cell.2015.07.015 · Cited by 1,068
Self-citationGong, S., Doughty, M., Harbaugh, C. R., Cummins, A., Hatten, M. E., Heintz, N., & Gerfen, C. R. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2707-07.2007 · Cited by 977
Gating of social reward by oxytocin in the ventral tegmental area
Hung, L. W., Neuner, S., Polepalli, J. S., Beier, K. T., Wright, M., Walsh, J. J., Lewis, E. M., Luo, L., Deisseroth, K., Dölen, G., et al. (2017) · Science · doi:10.1126/science.aan4994 · Cited by 578
Self-citationRudnick, G., & Wall, S. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1817 · Cited by 535
Griebel, G., Belzung, C., Perrault, G., & Sanger, D. J. (2000) · Psychopharmacology · doi:10.1007/s002130050038 · Cited by 420
Research works printed but not linked: 1
- S. Garattini R. Samanin Central Mechanisms of Anorectic Drugs (Monographs of the Mario Negri Institute for Pharmacological Research Raven Press 1978).
Cited by
Sorted by citations
Gregorio, D. D., Aguilar‐Valles, A., Preller, K. H., Heifets, B. D., Hibicke, M., Mitchell, J., & Gobbi, G. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1659-20.2020 · Cited by 279
Self-citationPsychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Yao, Y., Guo, D., Lu, T., Liu, F.-L., Huang, S., Diao, M.-Q., Li, S., Zhang, X.-J., Kosten, T. R., Shi, J., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115886 · Cited by 159
De Gregorio, D., Popic, J., Enns, J. P., Inserra, A., Skalecka, A., Markopoulos, A., Posa, L., Lopez-Canul, M., He, Q., Lafferty, C. K., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020705118 · Cited by 139
5-HT modulation of a medial septal circuit tunes social memory stability
Wu, X., Morishita, W., Beier, K. T., Heifets, B. D., & Malenka, R. C. (2021) · Nature · doi:10.1038/s41586-021-03956-8 · Cited by 116
Self-citationFenfluramine acts as a positive modulator of sigma-1 receptors
Martin, P., de Witte, P. A. M., Maurice, T., Gammaitoni, A. R., Farfel, G. M., & Galer, B. S. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.106989 · Cited by 100
Allosteric Modulation of Neurotransmitter Transporters as a Therapeutic Strategy
Niello, M., Gradisch, R., Loland, C. J., Stockner, T., & Sitte, H. H. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.04.006 · Cited by 81
Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal
Pomrenze, M. B., Pinto, D. F. C., Neumann, P. A., Llorach, P., Tucciarone, J., Morishita, W., Eshel, N., Heifets, B. D., & Malenka, R. C. (2022) · Neuron · doi:10.1016/j.neuron.2022.09.024 · Cited by 79
Self-citationThe nucleus accumbens in reward and aversion processing: insights and implications
Xu, Y., Lin, Y., Yu, M., & Zhou, K. (2024) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2024.1420028 · Cited by 86
Therapeutic mechanisms of psychedelics and entactogens
Heifets, B. D., & Olson, D. E. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01666-5 · Cited by 70
Self-citationNeural circuits regulating prosocial behaviors
Walsh, J. J., Christoffel, D. J., & Malenka, R. C. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01348-8 · Cited by 72
Self-citationEntactogens: How the Name for a Novel Class of Psychoactive Agents Originated
Nichols, D. E. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.863088 · Cited by 67
Hariri, A. A., Cartwright, A. P., Dory, C., Gidi, Y., Yee, S. C., Thompson, I. A. P., Fu, K. X., Yang, K. Y., Wu, D., Maganzini, N., et al. (2023) · Advanced Materials · doi:10.1002/adma.202304410 · Cited by 63
Roberts, C., Sahakian, B. J., & Robbins, T. W. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.001 · Cited by 63
Myelin plasticity in the ventral tegmental area is required for opioid reward
Yalçın, B., Pomrenze, M. B., Malacon, K. E., Drexler, R., Rogers, A. E., Shamardani, K., Chau, I. J., Taylor, K. R., Ni, L., Contreras-Esquivel, D., et al. (2024) · Nature · doi:10.1038/s41586-024-07525-7 · Cited by 57
Self-citationWalsh, J. J., Llorach, P., Cardozo Pinto, D. F., Wenderski, W., Christoffel, D. J., Salgado, J. S., Heifets, B. D., Crabtree, G. R., & Malenka, R. C. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01091-6 · Cited by 56
Self-citationSelective filtering of excitatory inputs to nucleus accumbens by dopamine and serotonin
Christoffel, D. J., Walsh, J. J., Hoerbelt, P., Heifets, B. D., Llorach, P., Lopez, R. C., Ramakrishnan, C., Deisseroth, K., & Malenka, R. C. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2106648118 · Cited by 54
Self-citationInserra, A., Giorgini, G., Lacroix, S., Bertazzo, A., Choo, J. M., Markopolous, A., Grant, E., Abolghasemi, A., Gregorio, D. D., Flamand, N., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15977 · Cited by 41
Oeri, H. E. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120920420 · Cited by 43
MDMA enhances empathy-like behaviors in mice via 5-HT release in the nucleus accumbens
Rein, B. A., Raymond, K. B., Boustani, C., Tuy, S., Zhang, J., Laurent, R. S., Pomrenze, M. B., Boroon, P., Heifets, B. D., Smith, M. L., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl6554 · Cited by 40
Self-citationSerotonin-releasing agents with reduced off-target effects
Mayer, F. P., Niello, M., Cintulová, D., Sideromenos, S., Maier, J., Li, Y., Bulling, S., Kudlacek, O., Schicker, K. W., Iwamoto, H., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01843-w · Cited by 36
Sottile, R., & Vida, T. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.991753 · Cited by 41
MDMA and memory, addiction, and depression: dose-effect analysis
Pantoni, M. M., Kim, J. L., Alstyne, K. R. V., & Anagnostaras, S. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06086-9 · Cited by 41
Physical activity promotes brain development through serotonin during early childhood
Jing, J.-Q., Jia, S.-J., & Yang, C.-J. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.07.015 · Cited by 43
Filippo, R. D., Rost, B. R., Stumpf, A., Cooper, C., Tukker, J. J., Harms, C., Beed, P. S., & Schmitz, D. (2021) · eLife · doi:10.7554/elife.66960 · Cited by 34
A systematic review and meta-analysis of how social memory is studied
Cum, M., Pérez, J., Wangia, E., Lopez, N., Wright, E. S., Iwata, R. L., Li, A., Chambers, A. R., & Padilla-Coreano, N. (2024) · Scientific Reports · doi:10.1038/s41598-024-52277-z · Cited by 35
Shahrour, G., Sohail, K., Elrais, S., Khan, M. H., Javeid, J., Samdani, K., Mansoor, H., Hussain, S. I., Sharma, D., Ehsan, M., et al. (2024) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12485 · Cited by 31
Ketamine Analgesia and Psychedelia: Can We Dissociate Dissociation?
Mashour, G. A. (2022) · Anesthesiology · doi:10.1097/aln.0000000000004172 · Cited by 28
Damonte, V. M., Pomrenze, M. B., Manning, C., Casper, C., Wolfden, A. M., Malenka, R. C., & Kauer, J. A. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.06.011 · Cited by 31
Self-citationFriend of the Devil: Negative Social Influences Driving Substance Use Disorders
Pomrenze, M. B., Paliarin, F., & Maiya, R. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.836996 · Cited by 29
Dissecting neural mechanisms of prosocial behaviors
Walsh, J. J., Christoffel, D. J., Wu, X., Pomrenze, M. B., & Malenka, R. C. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.11.006 · Cited by 30
Self-citationCan psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
Ponomarenko, P., Seragnoli, F., Calder, A. E., Oehen, P., & Hasler, G. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231155117 · Cited by 31
Exploring the regulatory framework of psychedelics in the US & Europe
Behera, H. K., Joga, R., Yerram, S., Karnati, P., Mergu, T., Gandhi, K., Sowndharya, M., Nathiya, D., Singh, R. P., Srivastava, S., et al. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104242 · Cited by 26
Wu, H., Kakusa, B. W., Neuner, S., Christoffel, D. J., Heifets, B. D., Malenka, R. C., & Halpern, C. H. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2109269118 · Cited by 22
Self-citationChou, N., Shin, H., Kim, K., Chae, U., Jang, M., Jeong, U., Hwang, K. S., Yi, B., Lee, S. E., Woo, J., et al. (2021) · Advanced Science · doi:10.1002/advs.202103564 · Cited by 16
Regan, A., Margolis, S., de Wit, H., & Lyubomirsky, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258849 · Cited by 21
Looking beyond the opioid receptor: A desperate need for new treatments for opioid use disorder
Lee, Y. K., Gold, M. S., & Fuehrlein, B. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120094 · Cited by 20
Esaki, H., Sasaki, Y., Nishitani, N., Kamada, H., Mukai, S., Ohshima, Y., Nakada, S., Ni, X., Deyama, S., & Kaneda, K. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175653 · Cited by 18
Uncovering psychedelics: from neural circuits to therapeutic applications
Melani, A., Bonaso, M., Biso, L., Zucchini, B., Conversano, C., & Scarselli, M. (2025) · Pharmaceuticals · doi:10.3390/ph18010130 · Cited by 17
Noradrenergic Signaling Disengages Feedforward Transmission in the Nucleus Accumbens Shell
Manz, K. M., Coleman, B. C., Grueter, C. A., Shields, B. C., Tadross, M. R., & Grueter, B. A. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2420-20.2021 · Cited by 19
Rudin, D., McCorvy, J. D., Glatfelter, G. C., Luethi, D., Szöllősi, D., Ljubišić, T., Kavanagh, P. V., Dowling, G., Holy, M., Jäntsch, K., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01221-0 · Cited by 17
Gomez-Escolar, A., Folch‐Sanchez, D., Stefaniuk, J., Swithenbank, Z., Nisa, A., Braddick, F., Chaudhary, N. I., van der Meer, P. B., & Batalla, A. (2024) · CNS Drugs · doi:10.1007/s40263-024-01101-3 · Cited by 21
Tripathi, A., Bartosh, A., Mata, J., Jacks, C., Madeshiya, A. K., Hussein, U. K., Hong, L. E., Zhao, Z., & Pillai, A. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02675-6 · Cited by 17
Siemann, J. K., Grueter, B. A., & McMahon, D. G. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.12.010 · Cited by 17
Gray areas: Neuropeptide circuits linking the Edinger-Westphal and Dorsal Raphe nuclei in addiction
Pomrenze, M. B., Walker, L. C., & Giardino, W. J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108769 · Cited by 16
Collins, S. M., O’Connell, C. J., Reeder, E. L., Norman, S. V., Lungani, K., Gopalan, P., Gudelsky, G. A., & Robson, M. J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.930346 · Cited by 16
Generalizable Molecular Switch Designs for In Vivo Continuous Biosensing
Saunders, J., Thompson, I. A. P., & Soh, H. T. (2025) · Accounts of Chemical Research · doi:10.1021/acs.accounts.4c00721 · Cited by 14
Trauma under psychedelics: how psychoactive substances impact trauma processing
Netzer, O., Magal, N., Stern, Y., Polinsky, T., Gross, R., Admon, R., & Salomon, R. (2025) · World Psychiatry · doi:10.1002/wps.21363 · Cited by 15
5-HT2C receptors in the nucleus accumbens constrain the rewarding effects of MDMA
Pomrenze, M. B., Vaillancourt, S., Salgado, J. S., Raymond, K. B., Llorach, P., Sacai, H., Rijsketic, D. R., Hietamies, T. M., Touponse, G. C., Pinto, D. F. C., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03128-4 · Cited by 14
Self-citationHistorical and Modern Evidence for the Role of Reward Circuitry in Emergence
Heshmati, M., & Bruchas, M. R. (2022) · Anesthesiology · doi:10.1097/aln.0000000000004148 · Cited by 15
Bioisosteric analogs of MDMA : Improving the pharmacological profile?
Alberto‐Silva, A. S., Hemmer, S., Bock, H. A., da Silva, L. A., Scott, K. R., Kastner, N., Bhatt, M., Niello, M., Jäntsch, K., Kudlacek, O., et al. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16149 · Cited by 13
Pomrenze, M. B., Vaillancourt, S., Llorach, P., Rijsketic, D. R., Casey, A. B., Gregory, N. S., Zhao, W., Girard, T. E., Mattox, K. T., Salgado, J. S., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.04.020 · Cited by 14
Self-citationPsychedelics, entactogens and psychoplastogens for depression and related disorders
Hoyer, D. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70088 · Cited by 17
Zacher, A., Zimmermann, J., Cole, D. M., Friedli, N., Opitz, A., Baumgartner, M. R., Steuer, A., Verdejo-García, A., Stock, A., Beste, C., et al. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.04.010 · Cited by 11
The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice
Fleury, S., & Nautiyal, K. M. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03387-1 · Cited by 15
Avgana, H., Toledano, R. S., & Akirav, I. (2024) · Pharmaceuticals · doi:10.3390/ph17070846 · Cited by 11
Continuous optical detection of small-molecule analytes in complex biomatricesPreprint
Hariri, A. A., Cartwright, A. P., Dory, C., Gidi, Y., Yee, S. C., Fu, K. X., Yang, K. Y., Wu, D., Thompson, I. A. P., Maganzini, N., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.03.531030 · Cited by 10
Sharp, J. L., & Smith, M. A. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.805139 · Cited by 13
O’Reilly, K. C., Anacker, A. M. J., Rogers, T. D., Forsberg, C. G., Wang, J., Zhang, B., Blakely, R. D., & Veenstra-VanderWeele, J. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135027 · Cited by 8
Laurent, R. S., Kusche, K. M., Rein, B. A., Raymond, K. B., Kreitzer, A. C., & Malenka, R. C. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.10.021 · Cited by 11
Self-citationSmith, M. A., Schmidt, K. T., Sharp, J. L., Pearson, T., Davis, A. L., Gibson, A. N., & Potter, K. M. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174646 · Cited by 8
A Systematic Review of the MDMA Model to Address Social Impairment in Autism
Chaliha, D. R., Mamo, J. C. L., Albrecht, M. A., Lam, V., Takechi, R., & Vaccarezza, M. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210101130258 · Cited by 7
Stereoselective, sex-dependent 5-HT2A receptor modulation of cortical plasticity by MDMA in mice
Gaines-Smith, M., Silverman, J. M., Fiorillo, M., Younkin, J., Moore, K., Maltman, J. L., Revenga, M. D. L. F., Wolstenholme, J. T., Glennon, R. A., Dukat, M., et al. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-025-02313-x · Cited by 7
Heifets, B. D., & Malenka, R. C. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00803-8 · Cited by 7
Self-citationCocaine restricts nucleus accumbens feedforward drive through a monoamine-independent mechanism
Manz, K. M., Coleman, B. C., Jameson, A. N., Ghose, D., Patel, S., & Grueter, B. A. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01167-3 · Cited by 8
Román, V., Kedves, R., Kelemen, K., Némethy, Z., Sperlágh, B., Lendvai, B., & Vizi, E. S. (2021) · Physiological Reports · doi:10.14814/phy2.15088 · Cited by 7
Kim, S., Yang, S., Jung, J., Choi, J., Kang, M., & Joo, J. (2025) · Advanced Science · doi:10.1002/advs.202413786 · Cited by 5
Meinke, C., Quinlan, M. A., Paffenroth, K. C., Harrison, F. E., Fenollar‐Ferrer, C., Katamish, R. M., Stillman, I., Ramamoorthy, S., & Blakely, R. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03299-w · Cited by 5
Mayer, F. P., Niello, M., Bulling, S., Zhang, Y., Yang, L., Kudlacek, O., Holy, M., Kooti, F., Sandtner, W., Rudnick, G., et al. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109704 · Cited by 4
History, pharmacology and therapeutic mechanisms of 3,4‐methylenedioxymethamphetamine (MDMA)
Casey, A. B., & Heifets, B. D. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70225 · Cited by 4
Self-citationThe psychedelic-peptide paradox: a hormetic hypothesis
Carter, C. S. (2025) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2025.100303 · Cited by 4
Žuljević, M. F., Viđak, M., Vukojević, J., Hren, D., & Peričić, T. P. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015345 · Cited by 4
Johnson, C. B., Walther, D. M., Baggott, M. J., Baker, L. E., & Baumann, M. H. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001837 · Cited by 4
Serotonin modulates nucleus accumbens circuits to suppress aggression in mice
Zhang, Z., Touponse, G. C., Alderman, P. J., Yassine, T. A., Pomrenze, M. B., Harris, T., Shank, A. N., Malenka, R. C., & Eshel, N. (2026) · Nature Communications · doi:10.1038/s41467-026-69254-x · Cited by 4
Self-citationHaggarty, C. J., Bershad, A. K., Kumar, M. K., Lee, R., & de Wit, H. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16346 · Cited by 3
Chou, D., Peng, H., Lin, T., Hsieh, M., Lai, C., & Lee, C. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111201 · Cited by 3
Long, K. L. P., Hoglen, N. E. G., Keip, A. J., Klinkel, R. M., See, D. L., Maa, J., Wong, J. C., Sherman, M., & Manoli, D. S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.23.599940 · Cited by 3
Post-traumatic stress disorder in psychedelic research
Bostoen, T., Tap, S. C., Breeksema, J. J., & Schoevers, R. A. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.02.004 · Cited by 2
Pharmacological Evaluation of Tropane Analogues at the Serotonin Transporter
Avanes, A. A., Warren, H. T., Senthil, A., & Olson, D. E. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00443 · Cited by 2
Wang, T., & Wöhr, M. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106747 · Cited by 2
Timing is key for behavioural benefits of psychedelics
Woodburn, S. C., & Kwan, A. C. (2023) · Nature · doi:10.1038/d41586-023-01869-2 · Cited by 2
MDMA for treatment of PTSD and neurorehabilitation in military populations
Dunn, W., Bershad, A. K., Krantz, D. E., & Vermetten, E. H. G. J. M. (2024) · Neurorehabilitation · doi:10.3233/nre-230270 · Cited by 2
КОЗУБ, М. І., Skybina, K., Musatova, I. B., Prokopyuk, O., Gramatiuk, S. M., Tynynyka, L. M., Козуб, М. М., Taran, А. V., Nikolchenko, A. Y., & Prokopіuk, O. (2021) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2021.2.05 · Cited by 2
Schneider, K. N., Nota, M. H. C., Lazaro, H., Rijsketic, D. R., Jin, M., Neiswanger, C., Beck, A. I., Ressler, N., Zhang, J. J., Li, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.28.646066 · Cited by 2
Self-citationGoyal, A., Karanovic, U., Blaha, C. D., Lee, K. H., Shin, H., & Oh, Y. (2024) · ACS Omega · doi:10.1021/acsomega.4c01322 · Cited by 1
Smith, H. N., Jones, D. N., Munger, E. L., Hof, P. R., Sherwood, C. C., & Raghanti, M. A. (2025) · The Journal of Comparative Neurology · doi:10.1002/cne.70083 · Cited by 1
Wang, T., Schwarting, R. K. W., & Wöhr, M. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70226 · Cited by 1
Palacios-Lagunas, D. A., Hernández-Mondragón, J. C., Fuxé, K., Borroto‐Escuela, D. O., Crespo‐Ramírez, M., Pérez-Eugenio, F., & de la Mora, M. P. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174135 · Cited by 1
Liu, M., Ying, L., Luo, H., Huang, P., Chen, W., & Wu, J. (2026) · Neurobiology of Stress · doi:10.1016/j.ynstr.2026.100810 · Cited by 1
Timmerman, A., Pottie, E., & Stove, C. P. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04356-5 · Cited by 1
R -MDDMA is a Safer Analogue of MDMA with Therapeutic Potential
Vargas, M. V., Hatzipantelis, C. J., Dunlap, L. E., Tombari, R. J., Avanes, A. A., Vaillancourt, S., Llorach, P., Salgado, J. S., Heifets, B. D., & Olson, D. E. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00891 · Cited by 1
Self-citationThe Central Mechanisms by which illicit drugs lead to addiction
Ubeja, R., & Szujewski, C. C. (2022) · Journal of Student Research · doi:10.47611/jsrhs.v11i4.3077 · Cited by 1
Womperski, K., BOGACZ, R., Gaik, M., MAGDA, I., Woźniak, J., Ewa, U. R. A. M., & OSUCH, M. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.43.01.007 · Cited by 2
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-1 · Cited by 1
de Oliveira, A. M., Miranda, R. G., & Dorta, D. J. (2024) · Toxicology · doi:10.1016/j.tox.2024.153761 · Cited by 2
3,4-Methylenedioxymethamphetamine (MDMA) and Synaptic Dopamine
Rizzo, F. R., Bruno, A., Federici, M., & Mercuri, N. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_116-1 · Cited by 1
3,4-Methylenedioxymethamphetamine (MDMA) and Synaptic Dopamine
Rizzo, F. R., Bruno, A., Federici, M., & Mercuri, N. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_116 · Cited by 1
Mind the gap: A systematic review and meta-analysis of how social memory is studiedPreprint
Cum, M., Pérez, J. S., Wangia, E., Lopez, N., Wright, E. S., Iwata, R. L., Li, A. S., Chambers, A. R., & Padilla-Coreano, N. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.20.572606 · Cited by 1
Laurent, R. S., Kusche, K. M., Kreitzer, A. C., & Malenka, R. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.12.578709 · Cited by 1
Self-citationHyperactivity of the Amygdala Mediates Depressive-Like Phenotypes and Decreased Serotonin ReleasePreprint
Kim, K., Lai, Y., Gao, Q., Wang, H., Ying, K. T., Asim, M., & He, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.10.642393 · Cited by 1
Metadata
- Authors
- Heifets, B. D., Salgado, J. S., Taylor, M. D., Hoerbelt, P., Cardozo Pinto, D. F., Steinberg, E. E., Walsh, J. J., Sze, J. Y., & Malenka, R. C.
- Affiliations
- Stanford Medicine (US)
- Stanford University (US)
- Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, USA.
- Albert Einstein College of Medicine (US)
- Corresponding author
- Malenka, Robert C.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2019-12-11
- Volume
- 11
- Issue
- 522
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC7123941
- OpenAlex
- W2994786945
- Cited by
- 120
- References
- 42
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 25 · 2023: 12 · 2022: 17 · 2021: 18 · 2020: 10
- FWCI
- 13.14
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Science Translational Medicine (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (MH110610, MH115668, MG105839)
- National Institute on Drug Abuse (DA042012)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- MDMA, ecstasy, prosocial behavior, reward, addiction, abuse liability, serotonin release, fenfluramine, neural pathways, treatment development
- MeSH terms
- Animals, Brain, Dopamine, Female, Male, Mice, Inbred C57BL, Nucleus Accumbens, Receptors, Serotonin, Reward, Social Behavior, Receptors, Oxytocin, N-Methyl-3,4-methylenedioxyamphetamine, Dopamine Plasma Membrane Transport Proteins, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
